Hospitalization for patients with acute exacerbated chronic obstructive pulmonary disease (AECOPD) create a significant burden for the patients and healthcare system. Improvements to key elements of care are necessary in order to relieve these major burdens, according to new research published in International Journal of Chronic Obstructive Pulmonary Disease.
The study attempted to measure the implementation rates of acute and post-acute hospital care interventions for AECOPD through a 24-month retrospective medical chart review of consecutive AECOPD hospitalization cases at 3 public hospitals in Switzerland. The researchers identified AECOPD hospitalization by applying an electronic search to physicians’ documentations, to only include those who were hospitalized in the medical or respiratory ward at each hospital.
“In-hospital management of AECOPD is focused on the acute stage with demand-responsive measures, ie, pharmacotherapy, oxygen therapy and, if necessary, noninvasive ventilation or invasive mechanical ventilation,” the authors explained. “However, it must be acknowledged that exacerbations leading to hospitalizations are an acute and severe worsening of a preexisting chronic disease and harbor a high risk of recurrence.”
Of the 263 hospitalizations that were analyzed, the median length of stay was 9 days and 32% of hospitalizations consisted of patients with previous AECOPD hospitalizations. In addition, the implementation rates of 4 acute care interventions were greater than 75%, compared to less than 25% for the implementation rates of 5 post-acute care interventions.
The acute care implementation rate was 56% for the appropriate administration of antibiotics, with over-prescription in 38% of the cases and under-prescription in 6%. The interventions for smoking cessation were present in 47% of the currently smoking patients and the referral for rehabilitation was suggested in 24% of the cases.
“These findings of potential shortcomings in hospital care, however, require careful interpretation. The majority of the post-acute care interventions are not linked to clearly defined and traceable technical processes as acute care measures are (eg, radiologic imaging),” the authors wrote. “In some cases, self-management interventions and also smoking cessation interventions, for example, might have been delivered to patients without according documentation in the medical chart or in the discharge letter.”
The study demonstrated the need for improvements in post-acute care interventions for AECOPD. The researchers suggested better communication and documentation practices in order to improve patient care.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More